Pilot Study of Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients with Multiple Myeloma - Article
Clinical Trial: Pilot Study of Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients with Multiple Myeloma
This study is currently recruiting patients.
|Multiple Myeloma || Drug: Curcumin |
MedlinePlus related topics: Multiple Myeloma
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Dose Comparison, Safety/Efficacy Study
Expected Total Enrollment: 24
Study start: November 2004
- Patients with multiple myeloma who are asymptomatic and without serious or imminent complications.
- Adequate hematologic, renal, and hepatic functions.
- ECOG performance status 0, 1, or 2.
Location and Contact Information
UT MDAnderson Cancer Center, Houston, Texas, 77030, United States; Recruiting
Saroj Vadhan-Raj, MD, Principal Investigator
Record last reviewed: June 2005
Last Updated: June 30, 2005
Record first received: June 10, 2005
ClinicalTrials.gov Identifier: NCT00113841
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-07-05